【摘要】 目的分析对食管癌患者应用胸腹腔镜、食管癌根治术联合治疗的临床效果。方法选择2018年1月至2020年1月我院诊治的88例食管癌患者,随机分为对照组(行食管癌根治术)和观察组(行胸腹腔镜联合食管癌根治术)各44例,对比分析两组的临床指标、炎性因子指标及并发症发生率。结果与对照组相比,观察组的各项临床指标均明显大幅降低(P<0.05),治疗后观察组各项炎性因子指标远低于对照组(P<0.05),观察组6.82%(3/44)的并发症发生率远低于对照组(P<0.05)。结论应用胸腹腔镜、食管癌根治术联合治疗食管癌,患者的身体炎性反应及并发症发生率明显降低,住院时间亦大幅缩短,对其术后恢复具有积极影响,值得临床大力推广。更多还原

【Abstract】 Objective To analyze the clinical effect of joint treatment of esophageal cancer of laparoscopy and radical esophageal cancer. Methods 88 patients with esophageal cancer diagnosed and treated in our hospital from January 2018 to January 2020 were randomly divided into a control group( radical esophageal cancer surgery) and an observation group( thoracolaparoscopy combined with radical esophageal cancer surgery), 44 each. The clinical indicators, inflammatory factors, and complication rates of the two groups were compared and analyzed. Results Compared with the control group, the clinical indicators of the observation group were significantly reduced(P<0.05), after treatment, the inflammatory factor indexes of the observation group were lower than those of the control group(P<0.05), the complication rate of the observation group was lower than that of the control group(P<0.05). Conclusion The combined treatment of esophageal cancer with thoracolaparoscopy and radical esophageal cancer can significantly reduce the incidence of inflammatory reactions and complications, and shorten the length of hospital stay, which has a positive impact on postoperative recovery and is worthy of clinical promotion.更多还原